With the Proactive Health announcement, we offer easy at-home blood diagnostics every four months, a microdose of GLP-1 medication, and the true star of our program the powerful Noom Longevity Companion. This program is much more than just a medication, continued Cook
The 10 mg dose was not studied as a specific tier in Phase 2
[11] [12] With regard to cardiovascular health, the weight loss and metabolic improvements observed in trials are likely to confer indirect cardiovascular benefits
Micro-habits involve encouraging consumers to take easy first steps that lead up to big results, says Noom CMO Peter Scherr
For instance, the American Diabetes Association only recommends the use of GLP-1 drugs for weight loss for those with a body mass index, or BMI, of at least 30, or among those with a BMI of 27 or greater if they have at least one other condition such as type 2 diabetes, hypertension or high cholesterol
Studies from the National Institute on Aging examining body composition changes during GLP-1 therapy show that individuals over 50 who lost significant lean mass experienced measurable declines in grip strength, gait speed, and activities of daily living scores
